Skip to content

A prospective multi-center randomized controlled study of No.6 lymph node dissection in improving the positive rate of lymph nodes in laparoscopic hepatic flexure of colon cancer at different stages

A prospective multi-center randomized controlled study of No.6 lymph node dissection in improving the positive rate of lymph nodes in laparoscopic hepatic flexure of colon cancer at different stages

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056620
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-02-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

Intervention group:dissection of lymph node No.6a?No.6i?No.6v
Control group:without dissection of lymph node No.6a?No.6i?No.6v

Sponsors

The Fourth People's Hospital Affiliated to Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. 18 years old = age = 85 years old, regardless of gender; 2. Colon liver cancer was diagnosed by colonoscopy, CT and high-resolution MRI; 3. Histologically and pathologically diagnosed as adenocarcinoma; 4. Be able to come to the hospital for reexamination as required; 5. ECOG physical condition score 0-1; 6. Sign the informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Preoperative examination revealed distant metastasis; 2. Patients with intestinal obstruction, intestinal perforation and intestinal bleeding which need emergency operation; 3. Preoperative evaluation failed to achieve R0 resection; 4. patients with any unstable systemic diseases, include but are not limited to, severe infection, uncontrolled diabetes, unstable angina, cerebrovascular accident or transient ischemic attack, myocardial infarction, congestive heart failure, severe arrhythmia requiring medication, liver, kidney or metabolic diseases; diseases affecting patients' lives; 5. Other circumstances in which the investigator judges that the patient is not suitable for the clinical trial.

Design outcomes

Primary

MeasureTime frame
Detection of positive rate of lymph nodes in group 6 at different pathological stages;

Secondary

MeasureTime frame
Postoperative gastrointestinal function recovery;Overall survival;Disease free time;

Countries

China

Contacts

Public ContactQizhi Liu

The Fourth People's Hospital Affiliated to Tongji University

lqz2008lqz@126.com+86 15921132390

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026